Japan begins first dismantling of a commercial nuclear reactor
This is the first such attempt on a commercial unit in Japan, after Chubu Electric decided in 2008 to dismantle two reactors ...
Cleanup at Fukushima is stressful, dangerous
The Fukushima Daiichi nuclear power plant's radiation levels have significantly dropped since the meltdown in Japan 14 years ...
AFP on MSN5h
Robots to retrieve radioactive sandbags at Fukushima plant
TOKYO: Robots will begin moving sandbags that were used to absorb radiation-contaminated water after the 2011 Fukushima ...
The Star2d
Japan begins its first dismantling of a commercial nuclear reactor
On Monday, Chubu Electric began removing the top lid of ... a decades-long project to scrap the damaged reactors at Fukushima Daiichi plant, which was hit by a huge tsunami in 2011, triggering ...
Power Engineering1d
‘Nervous and rushed’: Massive Fukushima plant cleanup work involves high radiation and stress
As workers remove melted fuel debris from the reactors, they are facing both huge amounts of psychological stress and ...
朝日新聞社6d
13 years after Fukushima meltdown, the head of nuclear cleanup is probing mysteries inside reactors
A decades-long project to clean up the remains of the Fukushima Daiichi nuclear power plant ... head of decommissioning for Tokyo Electric Power Company Holdings, in an interview with The ...
UNITED STATES
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
Prime Minister's Office of Japan3d
Japan-Federated States of Micronesia Working Dinner (Summary)
On March 18, 2025, commencing at 6:20 pm for approximately 85 minutes, Mr. ISHIBA Shigeru, Prime Minister of Japan, had a ...
pharmaphorum1d
Update: Daiichi Sankyo says Plexxikon R&D unit will close down
Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...
pharmaphorum2d
AZ, Daiichi get FDA nod for Dato-DXd in breast cancer
AstraZeneca and Daiichi Sankyo have claimed FDA approval for a second antibody-drug conjugate (ADC) for breast cancer, hoping to build on the success of a partnership that already spawned a ...